Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 80

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 80
---
 computed in accordance with ASC Topic 718, excluding the effect of estimated forfeitures. For a description of the assumptions used in valuing these awards, see Note 13 to our consolidated audited financial statements included in our 2024 Annual Report.

(3) Dr. Malik was appointed to the Board on July 1, 2024.

(4) Mr. Sallin resigned from the Board on February 28, 2024.

The table below shows the aggregate number of option awards (exercisable and unexercisable) and unvested stock awards held by each non-employee director as of December 31, 2024.

| Name                          |     | Options outstanding 
 at fiscal year end  |       |     | Unvested stock awards at fiscal year end |       |
|:------------------------------|:----|:--------------------|------:|:----|:-----------------------------------------|------:|
| Timothy C. Barabe, M.B.A.     |     |                     | 7,600 |     |                                          | 5,933 |
| Carrie S. Cox                 |     |                     | 8,266 |     |                                          | 5,933 |
| Nishan de Silva, M.D., M.B.A. |     |                     | 7,600 |     |                                          | 5,933 |
| Murat Kalayoglu, M.D., Ph.D.  |     |                     | 7,600 |     |                                          | 5,933 |
| Kemal Malik, MBBS(1)          |     |                     | 7,600 |     |                                          | 5,933 |
| Aymeric Sallin(2)             |     |                     |     — |     |                                          |     — |
| Michael Singer, M.D., M.B.A.  |     |                     | 7,600 |     |                                          | 5,933 |
| Timothy A. Springer, Ph.D.    |     |                     | 7,600 |     |                                          | 5,933 |
| Patrick Zenner, M.B.A.        |     |                     | 7,600 |     |                                          | 5,933 |

(1) Dr. Malik was appointed to the Board on July 1, 2024.

(2) Mr. Sallin resigned from the Board on February 28, 2024.

<div align='center'>47</div>

#### Equity Compensation Plan Information
The